GPT and asthenia: Thirteen drug-related grade 3 toxicities reported in eight patients, all at dose level 2, included neutropenia in six patients (37.5%), leucopenia in two patients (12.5%), and anaemia, thrombocytopenia, asthenia, stomatitis, and increased alanine aminotransferase levels in individual patients.